Use of biomarkers in the early diagnosis of Ischemic Stroke: A Systematic Review
Open Access
- 14 January 2026
- journal article
- review article
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
Abstract
The diagnosis of acute ischemic stroke (AIS) is time-sensitive and reliant on neuroimaging, which is not always immediately accessible. This systematic review aims to identify and evaluate bloodbased biomarkers with potential to support early diagnostic decision-making and facilitate prompt referral for confirmatory imaging and treatment. Following the PRISMA guidelines, a systematic search of PubMed, Web of Science, LILACS, Medline, Scopus, Scielo, Epistemonikos and TRIP Data Base was conducted for primary studies published in the last five years. Original studies evaluating blood-based biomarkers collected within 12 hours of symptom onset for early diagnosis of AIS were included. The methodological quality of included studies was assessed using the QUADAS-2 tool. Ten studies met the inclusion criteria, investigating a range of biomarkers including proteins, non-coding RNAs, and lipids. Most studies were case-control in design, with overall risk of bias rated as low to moderate. Multi-marker panels combining biomarkers with clinical scales (e.g., D-dimer and GFAP with FAST-ED; AUC = 0.95), and lipidomics-based models (AUC = 0.968), demonstrated the highest diagnostic performance. Several individual non-coding RNAs also showed promising accuracy (AUC > 0.85). Blood-based biomarkers, especially when used in multi-marker panels, demonstrate considerable potential as triage tools for early AIS diagnosis. Their application in point-of-care settings could reduce diagnostic uncertainty and accelerate time to treatment. However, prospective validation in real-world emergency environments is essential prior to clinical implementation.Keywords
This publication has 33 references indexed in Scilit:
- Circulating miR-574–5p shows diagnostic and prognostic significance and regulates oxygen-glucose deprivation (OGD)-induced inflammatory activation of microglia by targeting ATP2B2Molecular and Cellular Probes, 2025
- Diagnostic performance of plasma D-dimer, fibrinogen, and D-dimer to fibrinogen ratio as potential biomarkers to predict hypertension-associated acute ischemic strokeHeliyon, 2024
- Nesfatin-1: A Biomarker and Potential Therapeutic Target in Neurological DisordersNeurochemical Research, 2023
- Identification of three potential novel biomarkers for early diagnosis of acute ischemic stroke via plasma lipidomicsMetabolomics, 2023
- Plasma miR‐409‐3p promotes acute cerebral infarction via suppressing CTRP3The Kaohsiung Journal of Medical Sciences, 2020
- Biomarker Application for Precision Medicine in StrokeTranslational Stroke Research, 2019
- A Test in Context: D-DimerJACC, 2017
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control studyThe Lancet, 2010
- TWEAKing tissue remodeling by a multifunctional cytokine: Role of TWEAK/Fn14 pathway in health and diseaseCytokine, 2007